Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02770924
Other study ID # CAAE 49921915.1.0000.5505
Secondary ID
Status Completed
Phase Phase 4
First received May 4, 2016
Last updated September 13, 2017
Start date May 2016
Est. completion date September 13, 2017

Study information

Verified date August 2017
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the visual function of patients with bilateral implantation of the IOL trifocal ZEISS AT LISA TRI AND TRI TORIC by means of visual acuity tests with and without optical correction, sensitivity curve contrast, defocus curve and quality questionnaire visual function (VFQ-25).


Description:

Twenty patients (40 eyes) diagnosed with cataracts and cataract surgery indication will be selected to participate in this study. The surgery will be performed by the same surgeon with 2 week interval between surgery the first and second eye. After approval of the research project by the Research Ethics Committee all patients should understand and sign the Informed Consent and Informed (IC) before surgery.

All patients will be operated by conventional phacoemulsification with implantation of intraocular lens provided by the manufacturer.

Patients will have five study visits, including the preoperative visit, operative visit four postoperative visits.

All patients will be submitted to the following routine assessments preoperatively and demographic patient information will be recorded and a detailed medical history will be obtained.

- VFQ-25 Questionnaire

- Identification of the dominant eye;

- Visual acuity

- Refraction

- Slit lamp examination

- Tonometry

- Self-keratometry;

- Corneal topography;

- Microscopy speculate

- Fundus examination.

In addition, all routine preoperative measures will be performed. lens power calculations should be performed on both eyes to ensure qualification (lens power within the diopter range (D) available) and prepare for surgery (getting the lens). The emmetropia (± 0.5 D) should be the target of patients.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date September 13, 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Patients older than 50 years

- Cataract diagnosis indicating surgery in both eyes

- Corneal astigmatism to 12D (AT lisa tri toric)

- Corneal astigmatism less than 0,75D (AT lisa tri)

- Ability to provide consent and clarification for study participation

Exclusion Criteria:

- Significant irregular corneal astigmatism as shown by Corneal topography;

- Corneal astigmatism up 12D

- Patients diagnosed with severe visual degenerative disorders (e.g. macular degeneration or other disorder of the retina)

- Previous corneal surgery;

- Amblyopia

- Planning for multiple procedures, including IRL, LASIK, etc. during surgery or during the study

- Endothelial dystrophy clinically significant cornea (eg, Fuchs dystrophy)

- Corneal disease activity (eg, herpes simplex, herpes zoster, etc.)

- Severe diabetic retinopathy

- Retinal detachment

- Glaucoma

- Patients presenting illness or acute conditions or chronic severe that in the opinion of the investigator, would increase the surgical risk or confound the research results

- Any patient who is taking part in another study involving ocular surgery

Study Design


Related Conditions & MeSH terms


Intervention

Device:
AT LISA TRI TORIC
phacoemulsification with IOL implantation
AT LISA TRI
phacoemulsification with IOL implantation

Locations

Country Name City State
Brazil Eye Clinic São Paulo
Brazil IPEPO São Paulo

Sponsors (3)

Lead Sponsor Collaborator
Federal University of São Paulo Eye Clinic Day Hospital, São Paulo, Instituto Paulista de Estudos e Pesquisa em Oftalmologia

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Binocular visual acuity for far, intermediate and near distance Visual acuity measurements Changes from Pre-Op to Month 3
Secondary Defocus Curve Test of Defocus Curve Month 3
Secondary Contrast Sensitivity Compare scores of contrast sensitivity pre-op and post-op Changes from Pre-Op and Month 3
Secondary VFQ-25 Questionnaire Compare answers between pre-op and post-op Changes from Pre-Op and Month 3
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A